Trending Stories4 months ago
FDA Panel Recommends Aduhelm (Donanemab) for Early Alzheimer’s Disease
A Beacon of Hope: FDA Panel Recommends Aduhelm (Donanemab) for Early Alzheimer’s Disease Alzheimer’s disease, a progressive and debilitating neurodegenerative disorder, has long been a source...